The trading price of Park Ha Biological Technology Co Ltd (NASDAQ:PHH) floating higher at last check on current market day and closing at $23.46, 7.07% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $21.0 and $24.1427. The company’s P/E ratio in the trailing 12-month period was 405.18. In examining the 52-week price action we see that the stock hit a 52-week high of $22.62 and a 52-week low of $3.70. Over the past month, the stock has gained 65.44% in value.
Park Ha Biological Technology Co Ltd, whose market valuation is $618.64 million at the time of this writing, is expected to release its quarterly earnings report in July. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0 per share this quarter, however they have predicted annual earnings per share of 0 for current year and 0 for next year.
A quick review shows that PHH’s price is currently 37.90% off the SMA20 and 55.68% off the SMA50. The RSI metric on the 14-day chart is currently showing 78.08, and weekly volatility stands at 6.65%. When measured over the past 30 days, the indicator reaches 5.24%. Park Ha Biological Technology Co Ltd (NASDAQ:PHH)’s beta value is currently sitting at 0, while the Average True Range indicator is currently displaying 1.90.
To see how Park Ha Biological Technology Co Ltd stock has been performing today in comparison to its peers in the industry, here are the numbers: PHH stock’s performance was 7.07% in the latest trading. Park Ha Biological Technology Co Ltd has a P/E ratio of 405.18.
An evaluation of the daily trading volume of Park Ha Biological Technology Co Ltd (NASDAQ:PHH) indicates that the 3-month average is 391.56K. However, this figure has increased over the past 10 days to an average of 0.33.
Currently, records show that 25.00 million of the company’s shares remain outstanding. The insiders hold 81.71% of outstanding shares, whereas institutions hold 0.19%. The stats also highlight that short interest as of 2025-05-30, stood at 65869.0 shares, resulting in a short ratio of 0.2 at that time. From this, we can conclude that short interest is 90.00 of the company’s total outstanding shares. It is noteworthy that short shares in May were down slightly from the previous month’s figure, which was 0.1 million. However, since the stock’s price has seen 272.97% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
